Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma : prospective non-controlled study.

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma : prospective non-controlled study. - Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002497

Enrollment

Registered

2009-10-01

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant brain tumor

Interventions

Oral administration of 5-aminolevulinic acid one hour before operation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gadolinium enhanced brain tumors on magnetic resonance images

Exclusion criteria

Exclusion criteria: Porphyria Patients who did not agree with this study Patients whom doctors decided as not a candidate

Design outcomes

Primary

Measure	Time frame
Evaluation of the tumor resection rate	—

Secondary

Measure	Time frame
Analysis of patients prognosis and side effects	—

Countries

Japan

Contacts

Public ContactTakuya Akai

Kanazawa Medical University Department of Neurosurgery

neurosur@kanazawa-med.ac.jp076-286-3511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026